KALA BIO, Inc.
KALA
Rank in Stocks
#30756
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Share Price
$0.75
Last synced: 2026-07-31
Market Cap
$14.50M
Change (1 day)
2.78%
Change (1 year)
-98.28%
Country
US
Trade KALA BIO, Inc. (KALA)
Category
Healthcare
Stock price history for KALA BIO, Inc. (KALA)
Highest end of day price: $0.28 on 2026-10-01
Lowest end of day price: $37.46K on 2018-01-01
Lowest end of day price: $37.46K on 2018-01-01
Stock price history of KALA BIO, Inc. from 2018 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -63.88% |
| 2025 | -88.09% |
| 2024 | -12.41% |
| 2023 | -37.21% |
| 2022 | -84.21% |
| 2021 | -79.90% |
| 2020 | 49.13% |
| 2019 | 15.30% |
| 2018 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
